The Lynx Group

Howard L. Kaufman, MD, FACS


Authored Items

The Cancer Immunotherapy Trials Network: A National Strategy for the Development and Implementation of Immunotherapy for the Treatment of Cancer

November 2012, Vol 1, No 5 - Immunotherapy

Key Points The clinical development of immunotherapy has lagged behind the theoretical and preclinical models, but the potential for durable therapeutic responses has been recognized for many years The lack of widespread clinical expertise with immunotherapy presents a challenge for fully realizing the therapeutic opportunities of emerging immunotherapeutic strategies The [ Read More ]

Sign me up!